Strategic Guidance for Evidence-Based Clinical Development
At HSP Research Group LLP, we provide scientific guidance and development support for clinical research programs involving pharmaceutical products, novel drug-delivery systems, herbal and phytopharmaceutical candidates, nutraceuticals and other suitable healthcare innovations.
Our clinical-development support focuses on study strategy, clinical study concepts, protocol-development support, CRO coordination, scientific documentation, data review and interpretation.
We help clients translate preclinical findings and product-development knowledge into structured clinical research strategies, with consideration of the target indication, patient population, route of administration, study objectives, endpoints, safety considerations and applicable regulatory requirements.
ICH E8(R1) emphasizes designing quality into clinical studies, protecting study participants, ensuring reliable results and identifying factors critical to study quality during planning and conduct
